NANO PRIME SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA

Their core work

Nano Prime is a Polish nanotechnology SME that manufactures and engineers nanostructured surfaces and nanomaterials, with demonstrated expertise in electrospinning, atomic layer deposition (ALD), and sol-gel processes. Their work sits at the intersection of nanofabrication and biomedical applications: they have contributed industrial manufacturing know-how to consortia developing photonic metal oxide nanostructures for cancer cell detection and nanoengineered titanium-zirconium surfaces for dental implants. As a small company embedded in academic MSCA-RISE consortia, their practical value is translating laboratory nanofabrication methods into manufacturable, surface-modified components — particularly for medical devices requiring controlled osseointegration or optical sensing properties.

What they specialise in

How they've shifted over time

Both of Nano Prime's projects started in 2018 and ran concurrently through 2023, so there is no clear chronological pivot — the "early" vs "recent" keyword split in this case reflects two parallel application tracks rather than a genuine timeline shift. Their first track (CanBioSe) centered on metal oxide nanostructures and optical biosensing for cancer diagnostics; the second (NanoSurf, carrying nearly three times the budget) focused on Ti-Zr alloy surfaces, osseointegration, and dental implantology. The heavier investment in NanoSurf suggests that medical device surface engineering — rather than diagnostic nanostructures — is where they see their stronger industrial opportunity.

With the larger of their two projects oriented toward dental implant osseointegration and the full suite of dental surgery keywords appearing in NanoSurf, Nano Prime appears to be positioning electrospinning and surface nanostructuring as an industrial service for the medical device and implantology manufacturing sector.

How they like to work

Nano Prime has participated exclusively as a partner — never as a coordinator — across both projects, which is consistent with a small manufacturing SME contributing specific process capabilities (electrospinning, ALD, surface finishing) to consortia led by universities or research institutes. Despite their small size, they reached 19 unique partners across 10 countries in just two MSCA-RISE projects, which is a broad network for this participation level. MSCA-RISE involves staff secondments, so working with them likely means researchers and technologists moving between labs, which suggests a hands-on, collaborative working style rather than a purely contractual one.

Nano Prime has built connections with 19 distinct consortium partners spread across 10 countries through just two projects, giving them a surprisingly wide European network for an SME of their scale. Their participation in MSCA-RISE schemes specifically implies active cross-institutional staff exchange rather than passive subcontracting.

What sets them apart

Nano Prime occupies an unusual niche as a Polish industrial SME with hands-on nanofabrication capabilities — electrospinning, ALD, sol-gel, LIPSS — embedded directly into academic research consortia. This is rare: most companies at this scale are subcontractors, but their MSCA-RISE participation means they operate as genuine research partners. For consortium builders seeking an SME that can bridge lab-scale nanostructure fabrication with manufacturable medical device components, particularly in dental implants or optical biosensors, Nano Prime offers directly relevant process expertise from a central-eastern European manufacturing base.

Highlights from their portfolio

• NanoSurf
  Their largest project by budget (EUR 144,000), covering the full implant engineering chain from Ti-Zr alloy selection through surface nanostructuring (LIPSS, sol-gel, electrospinning) to osseointegration assessment — the broadest technical scope in their portfolio.
• CanBioSe
  Demonstrates Nano Prime's reach into optical biosensing and early-stage cancer diagnostics using 1D photonic metal oxide nanostructures, showing their electrospinning and ALD capabilities applied outside the implant domain.